These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12560588)

  • 1. Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes.
    Kondo A; Manabe M; Saito K; Maekawa M; Kanno T
    J Atheroscler Thromb; 2002; 9(6):280-7. PubMed ID: 12560588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between high-density lipoprotein-cholesterol and malondialdehyde-modified low-density lipoprotein concentrations.
    Kondo A; Li J; Manabe M; Saito K; Kanno T; Maekawa M
    J Atheroscler Thromb; 2003; 10(2):72-8. PubMed ID: 12740480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of fibrate treatment on malondialdehyde-modified LDL concentration.
    Kondo A; Morita H; Nakamura H; Kotani K; Kobori K; Ito S; Manabe M; Saito K; Kanno T; Maekawa M
    Clin Chim Acta; 2004 Jan; 339(1-2):97-103. PubMed ID: 14687899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment.
    Song SH; Gray TA
    QJM; 2012 Oct; 105(10):973-80. PubMed ID: 22753665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
    Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
    Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
    Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf.
    Al-Rasadi K; Al-Zakwani I; Al Mahmeed W; Arafah M; Al-Hinai AT; Shehab A; Al Tamimi O; Alawadhi M
    Curr Med Res Opin; 2014 Dec; 30(12):2429-35. PubMed ID: 25222765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients.
    Galland F; Duvillard L; Petit JM; Lagrost L; Vaillant G; Brun JM; Gambert P; Vergès B
    Diabetes Metab; 2006 Dec; 32(6):625-31. PubMed ID: 17296517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patients.
    Kappelle PJ; Lambert G; Dullaart RP
    Atherosclerosis; 2011 Feb; 214(2):432-5. PubMed ID: 21122860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL.
    Kondo A; Muranaka Y; Ohta I; Notsu K; Manabe M; Kotani K; Saito K; Maekawa M; Kanno T
    Clin Chem; 2001 May; 47(5):893-900. PubMed ID: 11325894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atherogenic dyslipidaemia in type 2 diabetes].
    Zozulińska D
    Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S567-71. PubMed ID: 20527378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.
    Kappelle PJ; Dallinga-Thie GM; Dullaart RP;
    Biochim Biophys Acta; 2010 Jan; 1801(1):89-94. PubMed ID: 19800983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
    Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
    J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
    Brinton EA; Triscari J; Brudi P; Chen E; Johnson-Levonas AO; Sisk CM; Ruck RA; MacLean AA; Maccubbin D; Mitchel YB
    Lipids Health Dis; 2016 Jul; 15(1):116. PubMed ID: 27405296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.